Celltrion Healthcare Competitors and Similar CompaniesClear all
CureVac's competitors and similar companies include Candel Therapeutics and Amolyt Pharma.
 Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. |  Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. | ||
Founding Date | Founding Date 2000 | Founding Date 1999 | Founding Date 2015 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Needham, US HQ | Locations Écully, FR HQ Cambridge, US |
Employees | Employees 999 | Employees 50 | Employees 402% decrease |
Valuation ($) | Valuation ($) 648.3 m | Valuation ($) 176.8 m | Valuation ($) N/A |
Financial | |||
Net income | Net income (€260.2m) (FY, 2023) | Net income ($55.2m) (FY, 2024) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 1.1b | Total funding raised $ 64.6m | Total funding raised $ 93.1m |
For sources of this data, please see the company profile
View Company Profiles
Candel Therapeutics
HQ
Needham, US
Employees
50
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View companyAmolyt Pharma
HQ
Écully, FR
Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View company